✦ LIBER ✦

Second-Line Agents for Glycemic Control for Type 2 Diabetes: Are Newer Agents Better?

✍ Scribed by Zhang, Yuanhui; McCoy, Rozalina G.; Mason, Jennifer E.; Smith, Steven A.; Shah, Nilay D.; Denton, Brian T.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Third-Line Agent Selection for Patients

✍ Dr. Krystal L. Edwards; Dr. Carlos Alvarez; Brian K. Irons; Jessica Fields 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB

Continuous subcutaneous insulin infusion

✍ I-Te Lee; Yi-Ju Liau; Wen-Jane Lee; Chien-Ning Huang; Wayne H-H. Sheu 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

DB4 TREATMENT ADHERENCE AND BARRIERS TO

✍ F Alvarez-Guisasola; F Martin Castillo; G Krishnarajah; R Lyu; P Mavros; D Yin 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

A Systematic Review and Network Meta-Ana

✍ Orme, M.E.; Fenici, P.; Duprat Lomon, I.; Wygant, G.; Townsend, R.; Roudaut, M. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

Potential role of oral DPP-4 inhibitors

✍ A. Barnett 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB

First line chemotherapy for low or high

✍ Souchon, R.; Heidemann, E.; Hirschmann, W.; Minckwitz, G.v. 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 155 KB